These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 35118938)

  • 1. Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort.
    Ledger EVK; Sabnis A; Edwards AM
    Microbiology (Reading); 2022 Feb; 168(2):. PubMed ID: 35118938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions.
    Mohapatra SS; Dwibedy SK; Padhy I
    J Biosci; 2021; 46(3):. PubMed ID: 34475315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens.
    Roberts KD; Zhu Y; Azad MAK; Han ML; Wang J; Wang L; Yu HH; Horne AS; Pinson JA; Rudd D; Voelcker NH; Patil NA; Zhao J; Jiang X; Lu J; Chen K; Lomovskaya O; Hecker SJ; Thompson PE; Nation RL; Dudley MN; Griffith DC; Velkov T; Li J
    Nat Commun; 2022 Mar; 13(1):1625. PubMed ID: 35338128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of
    Vestergaard M; Nøhr-Meldgaard K; Bojer MS; Krogsgård Nielsen C; Meyer RL; Slavetinsky C; Peschel A; Ingmer H
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874470
    [No Abstract]   [Full Text] [Related]  

  • 5. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rediscovering the octapeptins.
    Velkov T; Roberts KD; Li J
    Nat Prod Rep; 2017 Mar; 34(3):295-309. PubMed ID: 28180225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
    Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics.
    Panjla A; Kaul G; Shukla M; Akhir A; Tripathi S; Arora A; Chopra S; Verma S
    Biomed Pharmacother; 2024 Jul; 176():116810. PubMed ID: 38823276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
    Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
    ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 11. History, Chemistry and Antibacterial Spectrum.
    Velkov T; Thompson PE; Azad MAK; Roberts KD; Bergen PJ
    Adv Exp Med Biol; 2019; 1145():15-36. PubMed ID: 31364069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational use of intravenous polymyxin B and colistin: A review.
    Zakuan ZD; Suresh K
    Med J Malaysia; 2018 Oct; 73(5):351-359. PubMed ID: 30350826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
    Velkov T; Roberts KD; Nation RL; Thompson PE; Li J
    Future Microbiol; 2013 Jun; 8(6):711-24. PubMed ID: 23701329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural biology of MCR-1-mediated resistance to polymyxin antibiotics.
    Materon IC; Palzkill T
    Curr Opin Struct Biol; 2023 Oct; 82():102647. PubMed ID: 37399693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in
    Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Mutational Scanning Reveals the Active-Site Sequence Requirements for the Colistin Antibiotic Resistance Enzyme MCR-1.
    Sun Z; Palzkill T
    mBio; 2021 Dec; 12(6):e0277621. PubMed ID: 34781730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
    Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to polymyxins in Gram-negative organisms.
    Jeannot K; Bolard A; Plésiat P
    Int J Antimicrob Agents; 2017 May; 49(5):526-535. PubMed ID: 28163137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis.
    Lyu C; Zhang Y; Liu X; Wu J; Zhang J
    BMC Infect Dis; 2020 Apr; 20(1):296. PubMed ID: 32316926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.